Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Neurology
2022 Mar 17;9820:e2046-e2059. doi: 10.1212/WNL.0000000000200660.
Show Gene links
Show Anatomy links
Spectrum of Phenotypic, Genetic, and Functional Characteristics in Patients With Epilepsy With KCNC2 Pathogenic Variants.
Schwarz N
,
Seiffert S
,
Pendziwiat M
,
Rademacher AV
,
Brünger T
,
Hedrich UBS
,
Augustijn PB
,
Baier H
,
Bayat A
,
Bisulli F
,
Buono RJ
,
Bruria BZ
,
Doyle MG
,
Guerrini R
,
Heimer G
,
Iacomino M
,
Kearney H
,
Klein KM
,
Kousiappa I
,
Kunz WS
,
Lerche H
,
Licchetta L
,
Lohmann E
,
Minardi R
,
McDonald M
,
Montgomery S
,
Mulahasanovic L
,
Oegema R
,
Ortal B
,
Papacostas SS
,
Ragona F
,
Granata T
,
Reif PS
,
Rosenow F
,
Rothschild A
,
Scudieri P
,
Striano P
,
Tinuper P
,
Tanteles GA
,
Vetro A
,
Zahnert F
,
Goldberg EM
,
Zara F
,
Lal D
,
May P
,
Muhle H
,
Helbig I
,
Weber Y
.
Abstract
BACKGROUND AND OBJECTIVES: KCNC2 encodes Kv3.2, a member of the Shaw-related (Kv3) voltage-gated potassium channel subfamily, which is important for sustained high-frequency firing and optimized energy efficiency of action potentials in the brain. The objective of this study was to analyze the clinical phenotype, genetic background, and biophysical function of disease-associated Kv3.2 variants.
METHODS: Individuals with KCNC2 variants detected by exome sequencing were selected for clinical, further genetic, and functional analysis. Cases were referred through clinical and research collaborations. Selected de novo variants were examined electrophysiologically in Xenopus laevis oocytes.
RESULTS: We identified novel KCNC2 variants in 18 patients with various forms of epilepsy, including genetic generalized epilepsy (GGE), developmental and epileptic encephalopathy (DEE) including early-onset absence epilepsy, focal epilepsy, and myoclonic-atonic epilepsy. Of the 18 variants, 10 were de novo and 8 were classified as modifying variants. Eight drug-responsive patients became seizure-free using valproic acid as monotherapy or in combination, including severe DEE cases. Functional analysis of 4 variants demonstrated gain of function in 3 severely affected DEE cases and loss of function in 1 case with a milder phenotype (GGE) as the underlying pathomechanisms.
DISCUSSION: These findings implicate KCNC2 as a novel causative gene for epilepsy and emphasize the critical role of KV3.2 in the regulation of brain excitability.
Bixby,
Zn2+-binding and molecular determinants of tetramerization in voltage-gated K+ channels.
1999, Pubmed
Bixby,
Zn2+-binding and molecular determinants of tetramerization in voltage-gated K+ channels.
1999,
Pubmed
Butler,
A family of putative potassium channel genes in Drosophila.
1989,
Pubmed
Calhoun,
Epilepsy Genetics: What Once Was Rare, Is Now Common.
2020,
Pubmed
Chow,
K(+) channel expression distinguishes subpopulations of parvalbumin- and somatostatin-containing neocortical interneurons.
1999,
Pubmed
Erisir,
Function of specific K(+) channels in sustained high-frequency firing of fast-spiking neocortical interneurons.
1999,
Pubmed
GBD 2016 Neurology Collaborators,
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
2019,
Pubmed
Gesche,
Patterns and prognostic markers for treatment response in generalized epilepsies.
2020,
Pubmed
Kaczmarek,
International Union of Basic and Clinical Pharmacology. C. Nomenclature and Properties of Calcium-Activated and Sodium-Activated Potassium Channels.
2017,
Pubmed
Källberg,
Template-based protein structure modeling using the RaptorX web server.
2012,
Pubmed
Lal,
Gene family information facilitates variant interpretation and identification of disease-associated genes in neurodevelopmental disorders.
2020,
Pubmed
Lau,
Impaired fast-spiking, suppressed cortical inhibition, and increased susceptibility to seizures in mice lacking Kv3.2 K+ channel proteins.
2000,
Pubmed
Maksemous,
Whole-Exome Sequencing Implicates SCN2A in Episodic Ataxia, but Multiple Ion Channel Variants May Contribute to Phenotypic Complexity.
2018,
Pubmed
Masnada,
Clinical spectrum and genotype-phenotype associations of KCNA2-related encephalopathies.
2017,
Pubmed
,
Xenbase
Muona,
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.
2015,
Pubmed
,
Xenbase
Ogiwara,
Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation.
2007,
Pubmed
Pérez-Palma,
Identification of pathogenic variant enriched regions across genes and gene families.
2020,
Pubmed
Rademacher,
Whole-Exome Sequencing in NF1-Related West Syndrome Leads to the Identification of KCNC2 as a Novel Candidate Gene for Epilepsy.
2020,
Pubmed
Rajakulendran,
Deletion of chromosome 12q21 affecting KCNC2 and ATXN7L3B in a family with neurodevelopmental delay and ataxia.
2013,
Pubmed
Reid,
Mechanisms of human inherited epilepsies.
2009,
Pubmed
Richards,
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
2015,
Pubmed
Romoli,
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences.
2019,
Pubmed
Rudy,
Kv3 channels: voltage-gated K+ channels designed for high-frequency repetitive firing.
2001,
Pubmed
Scheffer,
ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology.
2017,
Pubmed
Stern,
Mechanisms Underlying the Hyperexcitability of CA3 and Dentate Gyrus Hippocampal Neurons Derived From Patients With Bipolar Disorder.
2020,
Pubmed
Traynelis,
Optimizing genomic medicine in epilepsy through a gene-customized approach to missense variant interpretation.
2017,
Pubmed
Vetri,
A de novo heterozygous mutation in KCNC2 gene implicated in severe developmental and epileptic encephalopathy.
2020,
Pubmed
Waters,
Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes.
2006,
Pubmed
,
Xenbase
Weber,
The role of genetic testing in epilepsy diagnosis and management.
2017,
Pubmed
Yanagi,
Kv3.1-containing K(+) channels are reduced in untreated schizophrenia and normalized with antipsychotic drugs.
2014,
Pubmed
Yu,
Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy.
2006,
Pubmed
